Dutasteride, sold under the brand name Avodart among others, is a medication used primarily to treat enlarged prostate in men.
The global Dutasteride market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Dutasteride is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Dutasteride is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for Dutasteride is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key manufacturers of Dutasteride include GSK, Bionpharma, Rising Pharmaceuticals, Teva, Mylan, Zydus, Amneal Pharma, Apotex and Marksans Pharma, etc. In 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes:
This report presents an overview of global market for Dutasteride, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Dutasteride, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Dutasteride, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Dutasteride sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Dutasteride market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Dutasteride sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including GSK, Bionpharma, Rising Pharmaceuticals, Teva, Mylan, Zydus, Amneal Pharma, Apotex and Marksans Pharma, etc.
By Company
GSK
Bionpharma
Rising Pharmaceuticals
Teva
Mylan
Zydus
Amneal Pharma
Apotex
Marksans Pharma
Breckenridge Pharmaceutical
Segment by Type
Type I
Type II
Segment by Application
Hospital
Drug Store
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Dutasteride in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Dutasteride manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: China by type, by application sales and revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dutasteride sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Dutasteride Product Introduction
1.2 Market by Type
1.2.1 Global Dutasteride Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Type I
1.2.3 Type II
1.3 Market by Application
1.3.1 Global Dutasteride Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Drug Store
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Dutasteride Sales Estimates and Forecasts 2018-2029
2.2 Global Dutasteride Revenue by Region
2.2.1 Global Dutasteride Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Dutasteride Revenue by Region (2018-2023)
2.2.3 Global Dutasteride Revenue by Region (2024-2029)
2.2.4 Global Dutasteride Revenue Market Share by Region (2018-2029)
2.3 Global Dutasteride Sales Estimates and Forecasts 2018-2029
2.4 Global Dutasteride Sales by Region
2.4.1 Global Dutasteride Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Dutasteride Sales by Region (2018-2023)
2.4.3 Global Dutasteride Sales by Region (2024-2029)
2.4.4 Global Dutasteride Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Dutasteride Sales by Manufacturers
3.1.1 Global Dutasteride Sales by Manufacturers (2018-2023)
3.1.2 Global Dutasteride Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Dutasteride in 2022
3.2 Global Dutasteride Revenue by Manufacturers
3.2.1 Global Dutasteride Revenue by Manufacturers (2018-2023)
3.2.2 Global Dutasteride Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Dutasteride Revenue in 2022
3.3 Global Key Players of Dutasteride, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Dutasteride Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Dutasteride Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Dutasteride, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Dutasteride, Product Offered and Application
3.8 Global Key Manufacturers of Dutasteride, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Dutasteride Sales by Type
4.1.1 Global Dutasteride Historical Sales by Type (2018-2023)
4.1.2 Global Dutasteride Forecasted Sales by Type (2024-2029)
4.1.3 Global Dutasteride Sales Market Share by Type (2018-2029)
4.2 Global Dutasteride Revenue by Type
4.2.1 Global Dutasteride Historical Revenue by Type (2018-2023)
4.2.2 Global Dutasteride Forecasted Revenue by Type (2024-2029)
4.2.3 Global Dutasteride Revenue Market Share by Type (2018-2029)
4.3 Global Dutasteride Price by Type
4.3.1 Global Dutasteride Price by Type (2018-2023)
4.3.2 Global Dutasteride Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Dutasteride Sales by Application
5.1.1 Global Dutasteride Historical Sales by Application (2018-2023)
5.1.2 Global Dutasteride Forecasted Sales by Application (2024-2029)
5.1.3 Global Dutasteride Sales Market Share by Application (2018-2029)
5.2 Global Dutasteride Revenue by Application
5.2.1 Global Dutasteride Historical Revenue by Application (2018-2023)
5.2.2 Global Dutasteride Forecasted Revenue by Application (2024-2029)
5.2.3 Global Dutasteride Revenue Market Share by Application (2018-2029)
5.3 Global Dutasteride Price by Application
5.3.1 Global Dutasteride Price by Application (2018-2023)
5.3.2 Global Dutasteride Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Dutasteride Market Size by Type
6.1.1 US & Canada Dutasteride Sales by Type (2018-2029)
6.1.2 US & Canada Dutasteride Revenue by Type (2018-2029)
6.2 US & Canada Dutasteride Market Size by Application
6.2.1 US & Canada Dutasteride Sales by Application (2018-2029)
6.2.2 US & Canada Dutasteride Revenue by Application (2018-2029)
6.3 US & Canada Dutasteride Market Size by Country
6.3.1 US & Canada Dutasteride Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Dutasteride Sales by Country (2018-2029)
6.3.3 US & Canada Dutasteride Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Dutasteride Market Size by Type
7.1.1 Europe Dutasteride Sales by Type (2018-2029)
7.1.2 Europe Dutasteride Revenue by Type (2018-2029)
7.2 Europe Dutasteride Market Size by Application
7.2.1 Europe Dutasteride Sales by Application (2018-2029)
7.2.2 Europe Dutasteride Revenue by Application (2018-2029)
7.3 Europe Dutasteride Market Size by Country
7.3.1 Europe Dutasteride Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Dutasteride Sales by Country (2018-2029)
7.3.3 Europe Dutasteride Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Dutasteride Market Size
8.1.1 China Dutasteride Sales (2018-2029)
8.1.2 China Dutasteride Revenue (2018-2029)
8.2 China Dutasteride Market Size by Application
8.2.1 China Dutasteride Sales by Application (2018-2029)
8.2.2 China Dutasteride Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Dutasteride Market Size by Type
9.1.1 Asia Dutasteride Sales by Type (2018-2029)
9.1.2 Asia Dutasteride Revenue by Type (2018-2029)
9.2 Asia Dutasteride Market Size by Application
9.2.1 Asia Dutasteride Sales by Application (2018-2029)
9.2.2 Asia Dutasteride Revenue by Application (2018-2029)
9.3 Asia Dutasteride Sales by Region
9.3.1 Asia Dutasteride Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Dutasteride Revenue by Region (2018-2029)
9.3.3 Asia Dutasteride Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Dutasteride Market Size by Type
10.1.1 Middle East, Africa and Latin America Dutasteride Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Dutasteride Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Dutasteride Market Size by Application
10.2.1 Middle East, Africa and Latin America Dutasteride Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Dutasteride Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Dutasteride Sales by Country
10.3.1 Middle East, Africa and Latin America Dutasteride Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Dutasteride Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Dutasteride Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 GSK
11.1.1 GSK Company Information
11.1.2 GSK Overview
11.1.3 GSK Dutasteride Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 GSK Dutasteride Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GSK Recent Developments
11.2 Bionpharma
11.2.1 Bionpharma Company Information
11.2.2 Bionpharma Overview
11.2.3 Bionpharma Dutasteride Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Bionpharma Dutasteride Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bionpharma Recent Developments
11.3 Rising Pharmaceuticals
11.3.1 Rising Pharmaceuticals Company Information
11.3.2 Rising Pharmaceuticals Overview
11.3.3 Rising Pharmaceuticals Dutasteride Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Rising Pharmaceuticals Dutasteride Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Rising Pharmaceuticals Recent Developments
11.4 Teva
11.4.1 Teva Company Information
11.4.2 Teva Overview
11.4.3 Teva Dutasteride Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Teva Dutasteride Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Teva Recent Developments
11.5 Mylan
11.5.1 Mylan Company Information
11.5.2 Mylan Overview
11.5.3 Mylan Dutasteride Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Mylan Dutasteride Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Mylan Recent Developments
11.6 Zydus
11.6.1 Zydus Company Information
11.6.2 Zydus Overview
11.6.3 Zydus Dutasteride Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Zydus Dutasteride Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Zydus Recent Developments
11.7 Amneal Pharma
11.7.1 Amneal Pharma Company Information
11.7.2 Amneal Pharma Overview
11.7.3 Amneal Pharma Dutasteride Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Amneal Pharma Dutasteride Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Amneal Pharma Recent Developments
11.8 Apotex
11.8.1 Apotex Company Information
11.8.2 Apotex Overview
11.8.3 Apotex Dutasteride Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Apotex Dutasteride Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Apotex Recent Developments
11.9 Marksans Pharma
11.9.1 Marksans Pharma Company Information
11.9.2 Marksans Pharma Overview
11.9.3 Marksans Pharma Dutasteride Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Marksans Pharma Dutasteride Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Marksans Pharma Recent Developments
11.10 Breckenridge Pharmaceutical
11.10.1 Breckenridge Pharmaceutical Company Information
11.10.2 Breckenridge Pharmaceutical Overview
11.10.3 Breckenridge Pharmaceutical Dutasteride Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 Breckenridge Pharmaceutical Dutasteride Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Breckenridge Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Dutasteride Industry Chain Analysis
12.2 Dutasteride Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Dutasteride Production Mode & Process
12.4 Dutasteride Sales and Marketing
12.4.1 Dutasteride Sales Channels
12.4.2 Dutasteride Distributors
12.5 Dutasteride Customers
13 Market Dynamics
13.1 Dutasteride Industry Trends
13.2 Dutasteride Market Drivers
13.3 Dutasteride Market Challenges
13.4 Dutasteride Market Restraints
14 Key Findings in The Global Dutasteride Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
GSK
Bionpharma
Rising Pharmaceuticals
Teva
Mylan
Zydus
Amneal Pharma
Apotex
Marksans Pharma
Breckenridge Pharmaceutical
听
听
*If Applicable.